X4 Pharmaceuticals (XFOR) Misses Q4 EPS by 22c

X4 Pharmaceuticals (NASDAQ: XFOR) reported Q4 EPS of ($0.22). Revenue for the quarter came in at $2.57 million.

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Iridex Corp (IRIX) Misses Q2 EPS by 5c
• Sk Hynix Union Is Finalising Wording Of Tentative Wage Deal, And Will Brief Its Members On The Terms This Afternoon- Reuters